Peptide Decoding
Two peptide vials side by side on a dark surface
Step 02 / Compare

Compare peptides side by side

Type two or more compounds the way you'd type them into Google. Spelling doesn't have to be right.

2/4

Separate them with vs, a comma, or +. Up to 4 compounds.

Try

Acetyl Tetrapeptide-3 and Biotinoyl Tripeptide-1 are each a topical skincare peptide.

/compare/acetyl-tetrapeptide-3-vs-biotinoyl-tripeptide-1
ComparisonAcetyl Tetrapeptide-3
Capixyl · tetrapeptide-3
Biotinoyl Tripeptide-1
biotinyl-GHK · biotinyl tripeptide-1
How it works
How it works

This peptide is sold to strengthen how firmly a hair sits in the scalp, rather than to grow new hair directly.

How it works

The core of this molecule is GHK, the same tripeptide as the copper peptide, but the attachment is different and so is the use.

What it is
A hair peptide sold for thinning, with evidence that mostly belongs to a combination product.
GHK with a biotin tail, sold for hair and lashes rather than skin.
Status
Sold over the counterCosmetic ingredient
Sold over the counterCosmetic ingredient
Typical dose
How often
Daily
Daily
Stays active
Not measured, and not the right question
Not measured, and not the right question
Dose comes from
No established range
No established range
Cycled?
Not cycled Community practice
Not cycled Community practice
What it does
Drug class
Cosmetic peptide
Cosmetic peptide
Used for
A scalp peptide used for thinning hair and weak anchoring, usually as part of a branded blend rather than on its own.
A hair and lash peptide, used for thinning hair, weak lashes and shedding.
Receptors hit
Numbers
Full dose line
Serum or scalp treatment, 0.1 to 5%
Serum, 2 to 6 ppm typical in a finished product
Why that cycle
Used daily as part of a routine. The effect depends on continued use and fades when you stop, so there is nothing to cycle off.
Used daily as part of a routine. The effect depends on continued use and fades when you stop, so there is nothing to cycle off.
Weight / effect
Not measured in a trial
Not measured in a trial
Chain length
4 residues
3 residues
Common vial
Before you start
Route
On the skin (topical)
On the skin (topical)
Do not use if
Broken or actively inflamed scalp skin
A known allergy to any component of the finished product
Broken or actively inflamed scalp skin
A known allergy to any component of the finished product

What separates them

Proof behind the dose. Every dose here comes from community practice. Not one is backed by a published human study, which is worth knowing before you read the numbers as if they were equivalent.

What doesn't differ: They are both taken the same way (on the skin), aimed at the same thing (hair growth) and on the same schedule (daily). Neither has a measured effect size from a published trial, so there is no number to rank them on.

Difference map
Each column keeps its compound color below. A shared gray row means the same answer; colored cells show where they split.
Acetyl Tetrapeptide-3
Biotinoyl Tripeptide-1
PROOF
No established range
No established range

What people actually report

Acetyl Tetrapeptide-3

  • Very well tolerated in cosmetic use.
  • Occasional scalp irritation, usually from other ingredients in the formula.
Stop and get help if
  • A spreading rash or significant swelling where applied

Biotinoyl Tripeptide-1

  • Very well tolerated in cosmetic use.
  • Occasional irritation on the eyelid margin from lash products, usually from the formula rather than the peptide.
Stop and get help if
  • Eye irritation that does not settle after stopping a lash product
  • A spreading rash where applied

Side effects are what users and trials report most often, not a complete list. Anything sudden, spreading, or breathing-related is an emergency regardless of which compound caused it.

People also compare

This comparison does not cover cost, long-term safety, or how you personally will respond. Effect figures come from separate trials in different populations and are not always directly comparable to each other. Nothing here is medical advice or a recommendation to use any of these. Talk to a clinician about your own situation.

The published record

What Europe PMC and ClinicalTrials.gov hold for each, on the same rule.

Acetyl Tetrapeptide-3 has 2 records to Biotinoyl Tripeptide-1's 4. 0 original human studies against 0. Acetyl Tetrapeptide-3 has 0 registered trials to Biotinoyl Tripeptide-1's 2.

The published record

Research index

2

Records indexed for Acetyl Tetrapeptide-3

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 12 September 2026.

The published record

Research index

4

Records indexed for Biotinoyl Tripeptide-1

2 in humans, 0 of them original studies.

2 registered trials, 0 with posted results.

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 12 September 2026.

Commonly confused peptides

Long-form breakdowns of the pairs people confuse most, traced to primary sources.

Growth hormone

HGH vs Sermorelin

Distributing HGH for anti-aging is a federal felony carrying five years. Sermorelin lost to it commercially in 2008 and can still be legally compounded.

Read comparison ›
Muscle

IGF-1 LR3 vs IGF-1 DES

Neither has a single published human trial, and sources give LR3's half-life as anywhere from 6 to 30 hours. There is an FDA approved IGF-1, and it is neither of these.

Read comparison ›
Healing and recovery

Thymosin Alpha-1 vs LL-37

One is approved in 35 countries and its largest trial found nothing. The other has never been injected in a published study.

Read comparison ›
Metabolic and weight loss

Cagrilintide vs Semaglutide

Both were tested in the same trial, in the same people, over the same 68 weeks. Semaglutide won on weight, and the combination beat both while coming in below their sum.

Read comparison ›
Metabolic and weight loss

Retatrutide vs Tirzepatide

Retatrutide's 28.3 percent is being set against tirzepatide's 22.5 percent. Different trials, different lengths, and one of the numbers comes from a press release.

Read comparison ›
Sexual and hormonal

PT-141 vs Kisspeptin

Both are sold for sex. One works on desire and is FDA approved, the other works on hormones and stops working within two weeks.

Read comparison ›
Longevity

MOTS-c vs SS-31

One has an FDA approval and a failed Phase 3. The other has never been given to a person in a published study.

Read comparison ›
Growth hormone

Tesamorelin vs CJC-1295

Two GHRH analogs tested for the same condition. One completed two Phase 3 trials and got approved. The other's Phase 2 was halted in 2006 and never restarted.

Read comparison ›
Skin and repair

Melanotan I vs Melanotan II

Not two versions of one compound. One is an FDA approved implant for a rare disease, the other is approved nowhere and warned against by four regulators.

Read comparison ›
Longevity

Epitalon vs MOTS-c

Two longevity peptides with no published human trial between them. Epitalon's famous human data belongs to a bovine extract, and MOTS-c is something your body already makes.

Read comparison ›
Longevity

Glutathione vs NAD+

Both are sold as injections. NAD+ cannot enter cells intact, and a six month trial found oral glutathione raising body stores the injection is meant to fix.

Read comparison ›
Cognitive and mood

Semax vs Selank

Same Russian lab, same seven amino acids, built for different problems: Semax for alertness, Selank for anxiety.

Read comparison ›
Skin and repair

GHK-Cu vs Matrixyl

Two topical skin peptides with very different evidence: one carries copper, one carries a fat tail, and the most sold version of Matrixyl is built on the same tripeptide as GHK-Cu.

Read comparison ›
Healing and recovery

BPC-157 vs TB-500

Both are sold for tendon and muscle repair. BPC-157's human trials were enemas for ulcerative colitis, and TB-500's trials did not even use TB-500.

Read comparison ›
Growth hormone

CJC-1295 with DAC vs without DAC

One name, two drugs: one has a measured half-life and three published human trials, the other has never been tested in a person.

Read comparison ›
Growth hormone

Ipamorelin vs CJC-1295

They act on different receptors and are usually sold in the same vial. Each has human trials; the combination everyone buys has none.

Read comparison ›
Growth hormone

MK-677 vs Ipamorelin

Same receptor, a pill against an injection. MK-677 has far more human data, and that is exactly why we know more about what is wrong with it.

Read comparison ›
Healing and recovery

KLOW vs GLOW

These are not two products. One contains the other: KLOW is GLOW plus KPV, and neither blend has ever been tested as a blend.

Read comparison ›
Growth hormone

Sermorelin vs Ipamorelin

Two growth hormone peptides sold side by side. One was an approved drug and can still be compounded on prescription. The other was voted down in October 2024.

Read comparison ›

19 published

Compare is one of four tools on the site. See all tools.